Johnson David Michael
SEC insider (Form 3/4/5 filer). CIK 0001808098. Director at Zentalis Pharmaceuticals, Inc. (ZNTL) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 16, 2026. Located in BOSTON, MA.
Companies Johnson David Michael has filed insider reports for
- Zentalis Pharmaceuticals, Inc. (ZNTL): Director
- Aura Biosciences, Inc. (AURA): Director
Johnson David Michael
CIK: 0001808098
Transaction Breakdown
Open Market Buys (P)1 (20.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (80.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 16, 2026ZNTL
Zentalis Pharmaceuticals, Inc.
AwardDirect57.1K shares- - Jun 11, 2026AURA
Aura Biosciences, Inc.
AwardDirect15K shares- - Jun 17, 2025ZNTL
Zentalis Pharmaceuticals, Inc.
AwardDirect57.6K shares- - Jun 17, 2025AURA
Aura Biosciences, Inc.
AwardDirect13K shares- - May 16, 2025AURA
Aura Biosciences, Inc.
PurchaseDirect20K shares at avg. $4.90$98K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 16, 2026 |  ZNTL Zentalis Pharmaceuticals, Inc. | Award | 57,100 | - | $0 | Direct |
| Jun 11, 2026 |  AURA Aura Biosciences, Inc. | Award | 15,000 | - | $0 | Direct |
| Jun 17, 2025 | ZNTL Zentalis Pharmaceuticals, Inc. | Award | 57,603 | - | - | Direct |
| Jun 17, 2025 | AURA Aura Biosciences, Inc. | Award | 13,000 | - | - | Direct |
| May 16, 2025 | AURA Aura Biosciences, Inc. | Purchase | 20,000 | $4.90 | $98,000 | Direct |
1-5 of 5 transactions